We found that for the breast cancer surgery, propofol/remifentanil-based TIVA can effectively inhibit the increases of VEGF-C concentrations after surgery compared with sevoflurane-based inhalational anesthesia, whereas these two anesthetic methods produced similar effects on the release of TGF-β. The gene discussed is VEGFC; the disease is breast carcinoma.